Vice President, Pricing & Market Access

Who we are: Kymera is a clinical-stage biotechnology company pioneering the field of targeted protein degradation (TPD) to develop medicines that address critical health problems and have the potential to dramatically improve patients’ lives. Kymera is deploying TPD to address disease targets and pathways inaccessible with conventional therapeutics. Having advanced the first degrader into the clinic for immunological diseases, Kymera is focused on building an industry-leading pipeline of oral small molecule degraders to provide a new generation of convenient, highly effective therapies for patients with these conditions. Founded in 2016, Kymera has been recognized as one of Boston’s top workplaces for the past several years. For more information about our science, pipeline and people, please visit www.kymeratx.com or follow us on X (formerly Twitter) or LinkedIn . How we work: PIONEER : We are courageous, resilient and rigorous in our mission to improve patients’ lives through our revolutionary degrader medicines. COLLABORATE : We value trust + transparency from everyone. Our goals are shared, our decisions data-driven and our camaraderie genuine. BELONG : We recognize our differences, inviting curiosity and inclusivity, so that our people are valued, seen, and heard. How you’ll make an impact: The Head of Pricing & Market Access will lead global and U.S. pricing, reimbursement, access, and value strategies across Kymera's pipeline and future commercial products. Reporting to the Chief Commercial Officer, this executive will play a critical role in maximizing patient access and commercial value by shaping payer, provider, government, and health-system strategies from late-stage development through launch and lifecycle management. As a key member of the Commercial Leadership Team, this leader will partner closely with Marketing, Clinical Development, Medical Affairs, Regulatory, HEOR, Market Research, Finance, Business Development, and Corporate Strategy to ensure access considerations are embedded throughout development and commercialization planning. The ideal candidate will bring deep immunology expertise, preferably including atopic dermatitis and asthma, along with a proven track record of market access leadership across U.S. and global markets. Pricing Strategy Lead global and U.S. pricing strategies across the portfolio, including launch pricing, lifecycle pricing, contracting, and access optimization. Develop evidence-based pricing recommendations informed by market dynamics, unmet need, competitive landscapes, and payer insights. Oversee pricing governance and provide recommendations to executive leadership and the Board as needed. Assess pricing implications of business development opportunities and pipeline investments. Market Access & Reimbursement Develop market access and reimbursement strategies aligned with Kymera's commercialization roadmap, including planned launches in atopic dermatitis and asthma. Execute payer and reimbursement strategies to support successful launches and sustained access. Establish value propositions and access approaches for Commercial, Medicare, Medicaid, and international markets. Lead engagement strategies with U.S. payers, PBMs, integrated delivery networks, and government stakeholders. Value & Evidence Strategy Partner with Clinical Development, Medical Affairs, and HEOR to ensure evidence-generation plans meet payer, HTA, and reimbursement requirements. Shape endpoint, outcomes, and real-world evidence strategies that support differentiation and value demonstration. Guide development of value dossiers, AMCP materials, economic models, and HTA submissions. Launch Excellence Lead access readiness and launch planning for late-stage programs. Develop pricing, access, reimbursement, and uptake assumptions for forecasting. Identify and mitigate market access risks throughout development and commercialization. Leadership & Cross-Functional Influence Serve as the company's expert on payer